Browse Category

Market Analysis News 9 November 2025 - 10 November 2025

Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Novo Nordisk and Pfizer Stocks Today (Nov. 10, 2025): Pfizer Clinches $10B Metsera Deal as Novo Rises on Exit and India Brand Move

Published: November 10, 2025 Summary: On Monday, Pfizer said it will acquire obesity‑drug developer Metsera in a deal worth up to $10 billion, while Novo Nordisk shares climbed after bowing out of the bidding war. Governance drama around Novo’s board intensified as Norway’s $1.5 trillion sovereign wealth fund said it would abstain from key votes this week. Separately, Novo struck a distribution pact in India to sell a new branded version of its semaglutide weight‑loss shot. Reuters+3Reuters+3Reuters+3 Key takeaways How NVO and PFE are trading today Pfizer seals Metsera deal: what’s in it and why it matters Pfizer’s agreement to
Russian Stock Market Today (10.11.2025): MOEX Reclaims 2,600 as Ozon Lifts Guidance, Sberbank Signals Record Dividends, Oil Steadies Near $64

Russian Stock Market Today (10.11.2025): MOEX Reclaims 2,600 as Ozon Lifts Guidance, Sberbank Signals Record Dividends, Oil Steadies Near $64

The Russian equity market opened the week higher, with the MOEX Russia Index briefly topping 2,600 for the first time since late October as stronger oil, easing weekly inflation and upbeat corporate headlines buoyed sentiment. By late morning in Moscow, both benchmark indices were in the green while traders weighed a busy macro and sanctions calendar for the rest of November.  Ведомости+1 Market snapshot (as of Moscow time) Macro drivers: oil, sanctions and rates Corporate movers and news flow (10.11.2025) Ozon (OZON): stronger guidance + buybackE‑commerce marketplace Ozon raised its 2025 outlook, now expecting GMV growth of 41–43% and around ₽140bn in adjusted EBITDA, and announced a buyback
USD/CNY Today (10.11.2025): Yuan Holds Near 7.12 After Strong PBOC Fix — Outlook, Key Levels & What Could Move the Pair Next

USD/CNY Today (10.11.2025): Yuan Holds Near 7.12 After Strong PBOC Fix — Outlook, Key Levels & What Could Move the Pair Next

Updated: 10 November 2025 Key Takeaways Today’s USD/CNY Snapshot (10.11.2025) What this means: The stronger fix signals the PBOC’s continued preference to anchor the yuan and smooth day‑to‑day moves. CFETS (under PBOC authorization) publishes the fixing methodology, which blends market‑maker quotes and excludes extremes. chinamoney.com.cn What Moved the Yuan Today 1) A Firm PBOC Midpoint The PBOC fixed 7.0856, around 319 pips stronger than a consensus estimate, keeping the onshore pair near the low‑7.10s despite a choppy global backdrop. This has been a common playbook in recent weeks to curb volatility and keep expectations anchored. TradingView 2) Softer Dollar Pulse
10 November 2025
Bull Run or Bubble? Investors Eye New Highs as EUR/USD Rallies and Fed Prepares Cuts

USD/EUR Exchange Rate Today (10 November 2025): Euro Holds Near 1.156 vs Dollar as Senate Advances Shutdown Deal — Outlook Into US CPI and ECB Signals

USD/EUR today, 10 Nov 2025: EUR/USD trades around 1.156 as the U.S. Senate advances a bill to end the shutdown. What’s driving the move and where next ahead of Thursday’s U.S. CPI? Forecast, levels, and calendar inside. At a glance — today’s USD/EUR and EUR/USD Quick note: Many traders quote EUR/USD (dollars per euro). If you prefer USD/EUR (euros per dollar), it’s the inverse (1 ÷ EUR/USD). What moved the euro–dollar today (10 Nov 2025) 1) Washington moves toward ending the shutdownRisk appetite improved after a 60–40 procedural vote in the U.S. Senate to advance a House‑passed bill that would
10 November 2025
Tariff Shock and Fed Jitters: Asian Markets Stumble as Rally Meets Reality

What to Know Before the U.S. Stock Market Opens Today (Nov. 10, 2025): Futures Jump on Shutdown-Deal Hopes; Tyson, Occidental and AI Mega-Caps in Focus

TL;DR Futures and Global Backdrop U.S. equities are set to open higher Monday as traders react to signs of progress in Washington. Pre‑market, S&P 500 and Nasdaq‑100 futures rose while Dow futures edged up, tracking a global relief rally after the Senate took a procedural step toward ending the 40‑day federal shutdown. European and Asian bourses also advanced overnight. Reuters+1 The bid for risk assets follows a bruising week for U.S. tech where AI leaders led declines; today’s bounce centers on expectations that reopening the government would remove a growth headwind and reduce near‑term policy uncertainty. Washington: A Path to
Ethereum Price Today (Nov 10, 2025): ETH Jumps ~6% to ~$3,609 as ETF Outflow Shock Recedes; Countdown to ‘Fusaka’ Upgrade Begins

Ethereum Price Today (Nov 10, 2025): ETH Jumps ~6% to ~$3,609 as ETF Outflow Shock Recedes; Countdown to ‘Fusaka’ Upgrade Begins

Summary: Ether (ETH) rebounded sharply on Monday. At press time, ETH trades around $3,608.76, up about 6.4% over the past 24 hours, with an intraday range of $3,391–$3,648. The bounce comes despite last week’s heavy redemptions from U.S. spot Ethereum ETFs and as broader risk appetite improves to start the week. Looking ahead, Ethereum’s Fusaka network upgrade is locked in for December 3, a near‑term catalyst that will raise blob throughput via staged “BPO” forks and introduce several protocol tweaks. Saxo Bank+1 Ethereum price snapshot — Monday, Nov 10, 2025 Figures are based on live market data at the time
Crypto Frenzy: Bitcoin Wavers at $120K, Altcoins Roar, Regulators Act, and NFTs Rebound (July 22–23, 2025)

Bitcoin Price Today, Nov 10, 2025: BTC Reclaims $106K as U.S. Senate Moves to End Shutdown; ETFs Log ~$1.2B Weekly Outflow

Summary: Bitcoin (BTC) bounced back above $106,000 on Monday (10.11.2025), extending the weekend rebound after the U.S. Senate advanced a deal to reopen the federal government. The move came despite a sharp spot Bitcoin ETF net outflow of roughly $1.2 billion last week, suggesting sentiment is stabilizing after early‑November’s deleveraging. At press time, BTC hovered near $106K, up ~4% on the day. Reuters+1 Bitcoin price at a glance (10.11.2025) What’s moving BTC today Spot ETF flows: the numbers behind the headline Third‑party flow trackers show a whipsaw week for U.S. spot Bitcoin ETFs: Weekly net:~–$1.21B. The day‑by‑day data help reconcile
10 November 2025
AI Frenzy Fuels Record Wall St Rally as Shutdown Drags On – Key Market News (Oct 6-7, 2025)

Stock Market Today 10.11.2025

ENDEDLive coverage has endedEnded: November 11, 2025, 12:00 AM EST Is Zcash (ZEC) a Buy After a 1,000%+ Rally? November 10, 2025, 11:53 PM EST. Zcash has surged into the crypto spotlight, delivering a roughly 1,000%+ rally as investors chase privacy-focused assets. Like Bitcoin, Zcash caps supply at 21 million coins and follows a halving cadence that tightens new issuance. Its second halving in late 2024 mirrors mature cycles where scarcity often supports prices. The project's use of zk-SNARKs lets users transact privately, a distinct edge as on-chain activity faces more surveillance. Yet regulatory risk looms: policymakers have targeted privacy
10 November 2025
Berkshire Hathaway’s Next Act: Trillion-Dollar BRK-B, Buffett’s Farewell & 2025 Forecasts

BRK.A Stock Before the Bell (Nov 10, 2025): Record $381.7B Cash, OxyChem Deal Nears, PacifiCorp Risks, and Key Catalysts This Week

Date: Monday, November 10, 2025 Key takeaways Why the cash mountain matters before the openBerkshire finished Q3 with roughly $381.7 billion in cash and short‑term Treasuries—a U.S. corporate record. The scale of that reserve signals management’s caution on dealmaking and public‑equity valuations heading into year‑end, and it gives Berkshire unusual optionality if markets wobble. Note that Berkshire’s 10‑Q also highlights a more conservative, netted measure (cash, equivalents and T‑bills of $354.3 billion) after subtracting unsettled Treasury purchases; investors should be clear which metric they’re using when comparing across periods and peers. Reuters+1 Earnings check: insurance strength, steady rails/energyQ3 operating earnings
9 November 2025
Mastercard Stock Rockets on Q3 Earnings Beat and $2B Crypto Play – What Investors Should Know

Mastercard (MA) Stock: What to Know Before the Market Opens on November 10, 2025

Updated Sunday, November 9, 2025 Quick take Where MA stands into Monday’s openMastercard closed Friday at $551.97, about 8% below its 52‑week high ($601.77) and above its 52‑week low ($465.59). Expect official price discovery to resume at 9:30 a.m. ET Monday on the NYSE; pre‑opening order entry begins at 6:30 a.m. ET. Yahoo Finance+2Yahoo Finance+2 The newest headline to watchLate Sunday, Reuters reported that Visa and Mastercard are close to settling long‑running U.S. merchant litigation by trimming interchange fees by roughly a tenth of a percentage point on average over several years and allowing more flexibility to refuse certain card
9 November 2025
Visa (V) Stock Poised for a Surge? Crypto Pilot and Travel Deals Fuel Optimism

Visa (V) Stock: What to Know Before the Market Opens on November 10, 2025

Summary: Visa shares closed Friday at $336.02, about 10.5% below their 52‑week high. Over the weekend, reporting indicated Visa and Mastercard are nearing a settlement with U.S. merchants that would modestly reduce interchange fees—an overhang investors will weigh alongside Visa’s strong fiscal Q4 results, a higher dividend, and low‑double‑digit growth guidance for FY2026. Visa Investor Relations+1 KEY POINTS AT A GLANCE• Last close (Nov 7): $336.02; 52‑week range: $299.00–$375.51. Visa Investor Relations• Weekend headline: WSJ reporting (via Reuters) says Visa and Mastercard are close to a settlement with merchants that would trim swipe fees ~0.10 percentage point over several years
9 November 2025
AI Frenzy Fuels Record Wall St Rally as Shutdown Drags On – Key Market News (Oct 6-7, 2025)

Stock Market Today 09.11.2025

ENDEDLive coverage has endedEnded: November 10, 2025, 12:00 AM EST Surgery Partners (SGRY) Valuation Signals Undervaluation After Recent Rally November 9, 2025, 11:54 PM EST. Surgery Partners (SGRY) has gained ~9% over the last month, set against a tougher year with a -29% 1-year total shareholder return. The latest analysis argues the stock may be undervalued, with a fair value near $31 compared with the last close. The bull case rests on a narrative of high-single-digit growth and a rare, future profit multiple, supported by a shift of high-acuity procedures to outpatient settings and investments in robotics and facility capabilities.
9 November 2025
1 6 7 8 9 10 44
Go toTop